Traditional Chinese medicine composition for treating retinal pigment degeneration
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of retinal pigment and composition, which is applied in the field of traditional Chinese medicine, can solve the problems of poor curative effect of retinitis pigmentosa, achieve the effect of improving the symptoms of retinitis pigmentosa, no tolerance, and improved treatment effect
Inactive Publication Date: 2018-09-07
HUNAN UNIV OF CHINESE MEDICINE
View PDF3 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The purpose of the present invention is to overcome the disadvantages of the poor curative effect of the current treatment of
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0023] A Chinese medicinal composition for the treatment of retinitis pigmentosa. The components include: Rehmannia glutinosa 15-20g, Polygonatum 10-15g, Lycium barbarum 10-20g, Cuscuta 10-15g, Dogwood 10-15g, Yam medicine 10-20g, Poria 15-g 20g, Mushizi 10-15g, Dan Bark 10-15g, Panax notoginseng 10-15g, Danshen 10-20g, Achyranthes 10-15g, Angelica 10-20g, Shijue Ming 10-15g, Chuanxiong 10-15g, Qianghuo 10-15g, Shichangpu 10-15g. The key ingredients of this medicine are: Rehmannia, Polygonatum, Chinese wolfberry, Chinese yam and Panax notoginseng.
Embodiment 2
[0025] A Chinese medicinal composition for the treatment of retinitis pigmentosa. The components include: Radix Rehmanniae 15g, Polygonatum 10g, Lycium barbarum 15g, Cuscuta 10g, Dogwood 10g, Chinese Yam 10g, Poria cocos 15g, Fructus Chinensis 10g, Dan Bark 10g, Panax notoginseng 10g , Danshen 15g, Achyranthes 10g, Angelica 15g, Shijue Ming 10g, Chuanxiong 15g, Qianghuo 10g, Shichangpu 10g.
[0026] The above components are made into small pills according to modern preparation technology, and used for bottle equipment, 120g per bottle, 10g each time, 3 times a day, and warm boiled water after meals.
[0027] In order to show the therapeutic effect of the above-mentioned traditional Chinese medicine composition on RP, the present invention selects cases whose medical history, condition, age and sex are equivalent to the original treatment method, and compares the clinical therapeutic effects with the traditional Chinese medicine composition of the present invention:
[0028] Case 1: S...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the field of traditional Chinese medicine, and discloses a traditional Chinese medicine composition for treating retinal pigment degeneration, containing the following components: 15-20g of radix rehmanniae preparata, 10-15g of rhizoma polygonati, 10-20g of lycium barbarum, 10-15g of cuscuta Chinensis, 10-15g of dogwood, 10-20g of common yam rhizome, 15-20g of poria cocos,10-15g of fructus broussonetiae, 10-15g of cortex moutan, 10-15g of pseudo-ginseng, 10-20g of salvia miltiorrhiza, 10-15g of radix achyranthis bidentatae, 10-20g of angelica sinensis, 10-15g of concha haliotidis, 10-15g of ligusticum wallichii, 10-15g of notopterygium root and 10-15g of rhizoma acori graminei. The traditional Chinese medicine composition is prepared into pellets according to a modern preparation process, is bottled for later use, with 120g in each bottle, and is taken for 10g each time and three time each day, and taken with boiled water after a meal. The treatment effect ofthe traditional Chinese medicine composition for RP is remarkably improved in comparison with medicines on the market.
Description
Technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating retinitis pigmentosa. Background technique [0002] Retinitis pigmentosa (RP) is a group of hereditary retinal diseases characterized by the loss of photoreceptor and pigment epithelial function. Its main clinical features are night blindness, progressive visual field defects, characteristic changes in the fundus, and Abnormalities in the electrooculogram. According to different genetic methods, retinitis pigmentosa can be divided into autosomal dominant, autosomal recessive, chromosomal linkage, and a small number of double gene mutation inheritance and mitochondrial inheritance. The incidence of retinitis pigmentosa in the world is between 1 / 5000-1 / 3000, and it is one of the most common hereditary eye diseases that damage the fundus and cause blindness. Most patients with retinitis pigmentosa develop in adolescence...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more